ࡱ> FE}z#kNEJFIF,,C   %# , #&')*)-0-(0%()(C   (((((((((((((((((((((((((((((((((((((((((((((((((((}" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?Nvqwpp??QʒRI|n>|7IIA">|7EE4ۏ"M!_Q/)(ȣq_RQH_QIK="/);@yȣ'A=i}gM-.}g|J)_PO"{/('/))ig@>|CK@>|L/("ȤF}P()?E) WȢ /)#)i(h&Q#I?i?Ql7 g?ZRw-ԓVlL/(ϲ"(QeEeF)(CAAviuHZϩJRhM5T1ޞP(4 (E Z(I@ KIKH@ =h4`%/z(Gj@QEJZ(AE% Z((ZN(QERQ@G9斃F(4PMKmU_*CJ-%-%!R@4P (QIK@-%KIH@ E%- ){PJSI@!IKڀZ((ZJ(Q@-%- (%-J(j[n7TF/‡?QʛO~?6E-i@4P0Q@%- (hH4JZ(%-!)P5Wf 62}iQL QERPEQEJZJQESE.hh@55߅Djk_!ʛN~?6Š(Rb (&ZZF?.A ,rz랔nǭC!N:|ќdsϨ'=xySi}E-`%-P AQ' MfEXw$cq8fJao08NRAa&A Xȩ*U3]x>ϼ̧Ҳ..FI.sXxTVaʷțiڢR̄sO ۱c$095z jf;*m/Pg$23OMH.zS4 :ػaj" אN9 w5M: b3"p9Kqf?tTU4g;v6q5!v1 j^ ch@((=NHttp3ީY<wF Իc95^*Ј`nÌqQ^0 ~\u&06'bwȨRσOj\RFʻHeC9.6H lC|9Q^{`{qu+ R*ԗѯߨF=Kbj[iyG@NɎA ;7cJKjW'ASGlKC&RIJk(8 )KrXsk9 }QRQKILbTT&*O`G*m+A)( EPES6 2Z#TUڲ G89Ձuz!%(ngQ>qR@ϭs沆9HN8#{Թs~7e cjȳ(:M܋7^}RB@j Y+XbY\>N=~ ,P\(c?Uynr#U'kw: 0bps]IheVr85pQY6WAd~\$0vE*, o8,1*SҢq۞N*LXJ(i( ($Uܜ9aSJH3Tn8fTPO(c'@ҧ*p̧&>TVlc,Y<F1#׭GV5BXVP91^'`vp}=+cǦ+cv۸W-舘;-uVNHf]uFxu̸!sVl]2ɍ2m. ܘ9ϥr4)X~PFKt{+%˗ {uHށAErv9j J˙UJ=@$?AVVrĢ)RRPEP&!c$dT݀洮s޵2`rq@qZC%a1c(lӯCgsZ3{Fvu#8n-6Px,oB??^S㛛{VPOoκ=Pso<"$ v_6Ĝ5@j.Wo< ⸍eٮ?lBUL(\AmzWc,D*Jq4n6\r2p:v2T+ʃ?Ҝ]rpTd~OZ5PHU̇9P1V r܅;5T[CZx&1ןϊmx{ 1dݒ0}=hh;G&O85&т|qҤX:K|RgVU@\b9?3*ϓl Ƿzܼƻ&=?JgM -^1 HŔ e$"Hz1'>HXJ\m mcحM/Omܠ@OʵTo1Mdd~d[r:$c<ޡ 4Z$;' pzc=5 vֽ*МrrHG|2Cck{jy;;h;pP&=ߴʉ !ǦOj--2£aQn<{]n;fr?mm{xwI 9@ AMj#e`x 53ܤ:bRE1jkoMMmT=FG*m9T( (Hǃ@F}9`xq~pbd y#:Uߧ%nKӚA$j"X k#6qUfuYܓ{?_jj+0{>+˔#n+L}L?Z =k$ǏZm2M2mܞjHR=3qU7&mBjHVb7mˁ@ӼEwbߞt9ajz~LIxקqc=H)v\z \g[o*%ʶw=+cr77?#_һM-2<q-+swҬvMDarNOcծՋJZ(QKI@Q@c ֹQەYzz*N 'fW\zZbYMeTιvafcA/X^.E)Oi|uP>@R%Q>afI9eSiʛބފ( ?P3YR91,sd\r"#"bp"F9 g#{ןk7 cX7LcW6d{wIO, yRx].kW(19^U{+G)ɮi2gcnf+f~Nhsq]d8qv*I _ 5tW2QT"N>3 A#)]VaoGj}@IySl]TukʠdPzՏPd*a;ONy5鳳SUyןilA@*gK!+G_fĊV;Uk9UFT ISs=*d4 ;E (Ji( D,op>Rd. %]AGҵijddob}}Ѣ}(s_OlkwP< GҼ RnۺQ7b :" g ׯ6Xт`_@1\8&_76p3ǵ_9Tt'S4^gC"JCs<+~p*Z1qRzY+%*qgz|'V00^6! >W[0,N:gxv7(A}.23]Q)-Aa*TpGUUzk/Obzx }+XzR ( 0jk5=P7>Si}! KIISM4SCKMC@{Y6qy5ڜD]ʅ3ЂzצJ&w;13u]Y0U @*gvaQHO^S=9L]F+.1ϠvKs$(=ɸ,xfʮ*"S5#bIv yq$LSץ?X#1Xqݴ6bJ /9{h,݌>y1&BX"}BU\CIGeFg=y]#X?ҹ+UI Vn~-qs]g`=$xTpLFvmYLVOsAQE (0n玵k3I1ׂkHN9뎘ط!zֱؖqzFC,QyeiOw9@9׸j..33 60s+Ⱦ"X" #XؕVCW[$ֹ_ \4Wb":-#;rOz'0Qd`s+WvcP:[YāY:`eb# 6Iܢ<ڷϪD[h냊$'Ivq+0 H}RZ)R6L0P1=iO!9pckXmF]/ςz]>n R6CuDuzKHSVdiH9b&9>ڵgh{REIAIZ1@ j{o'>SM9Tiւ(J(Lqo~3 ǀ v],x@vs=qwZx,qAkH̨ ZD3m+!9Q}kM㞾^sf:n9#}B^ӏ8ÏOzL dV4vƯXj^۝Xu]<V%gsZu51b7=0m7`PqW#Z%h6APOJb"|!9WO<2wO}SDf0pNp3裫g&c0T߁یYoXNZܴ (PhPf*O`"*߯?Gޚå-'^)h;RRl4'tp[q*03\D f~IQN:az 1]}뜾TY 7yY& $_1`fc|W$rN8ju JInt8=z  k58g_VudݴڼĺMR':}k [jQEv+t[q"iBl /ZمȬ J%I%×ުy7 {WIn?sg.اU)'#ҺK5 {s[ēR&  3@5Fx)!hO*38$PCϽx\ p;T8K9`q6R,J(QL(MGz갖rx#q]A>?Z($mLOcڵij h]XaJ 럽M$vb`}p:u:FI"1unѕ]c@TuԎ$sLFr>g<8q<pk59-˷8ϯ^MÞk0f+ hf.A'swWO,'5> U0(pb&o&vzU,%dd8= u]bQ%y6 =zuFR91[fcTBE\czDQn@\ۿv8Lhc#OC&e*`ftU u֭l3B,B [qZy[Ȉu un cX3[4$d۸PꐄZć ۷Y:(HUz~?J R#nc (BJО_z9YUr2%JmPJ!WlgOC]1C s}I?s-.Crw.B}Eg$#Ѭ!(B_.Pb1~~ R]f84=r*L`Ӭ&4;wn͹@꤀=*VF(ɸςoJݱ1lBs1SZ! (%P s= th! ௰C(0ҷlPޕOa"Od*Oɴ@sGzps4İ(((ʮFGSMr{$ Hbuq\ 1ms>դv%Ԥm%s³`Tcy_Zն;Qlp#s@a UX6#6rx r3k_Lh`TXѭnTdU(U*+C˞AEX5) JM& Z-955>~=*=G'ʣ43*41wS @KHAM~ktrHcު\ǘ13Zdާh=Ds7̒/lӾkE瘧Bf?κe =Q/vhuB?*lE UUp}ޟ&:8N*4L -+'ϷbRa+1`b?. =A$ȲUֶ1P'I68 ӰlĠHe=6Ot0눃uہg?ʳAI~l?XŒn o#d;jG+zTVɹU3@`/Lld3<{x۸ǵKL]vߘc>ڝXQE0 ( (#'{VeŸ|1sZr 9Wx 3Uqǩ+#R2z/]f`u5shѣʁ !{j9fe>{ cOTe$ u(83y#kMju9#/ Mi|Tn%ak[t}`*yxMq?ZHyy(1O7*{~UcubC.7c$_V1X00HL-li1' }?i6lz+r%1H^4*.7j@aqIÀ@!#J%k1#d%15414NZ`8Pt"'ϠUTʘi4Q@֊SIH74Ҁ `AsisGjw>ǠV#:dX7H# oy>\"ȸ`̧Eaj2v{ִD<.SXx#ZBd? p;Uq>Q!8']AmU{zj`H,v2=OYx ps [zVUĮH m):##PpA[ֈk1 zm1<,oِwgb@E@cܨjP> ̓!#׭ILD89EIڳQEQES*6<ϽH0j7veU2bi$,Ő >Jߞ0=eN bƴB3U]1+$qS Yc#i#n8* ,)bv oUvqv1׽mȀ),0*Dnx]P1 Y3?\ճ)˓x4VLf~xc; M ;zg3MVlJò`p>%D!€pW;9jCIu6"֖PU_* Uo *<Ԓ ?FR >(?Z`0;:52֚ɧL9|8␆cFWqR4g}*eCN;v 91+HXZB-ҴBg7g/~fBGͱN=t!_2`áe< V%q 0 =kUUۧ5vG }+*r88E+?>0-iJ%hock`,8#@9Ա@|bt4d`JT1R;H#88=ݩđ#E@Ibc$OT J(E-QE5>}{qR r eldt?gҮ,LP1Qӹִ-oB:Yt v}V2b$\`bj%GU'+[cnp?:ž#dOV T1SU+7l6QֱҬR v%(@Up1!2- t8gqXא왾 GN󭉷FIGAzPF@jAN2G+q8PX`!C(1 :wB8diqY"Rv͌zqҟڣH3YWhh= QETT=koDG*i>SM4qZ'4iN|RaZ!>B"3& FՓ^ZBvm[YdqW3/Iq"ʼn~U#p1ֺޫJzV4jRp]NI{F )" H-28*zvQ*I #WRE|9! q׊^<ֳE\Z]H>L/C֜:MiZų83OQ4(F#n{ԔJ)i;E-!@ zgӭ8`FW9QQFz5s1Z J]k6$`#e5u ڭ c+To]8 AAqWp@[9f1G I8ôbw(?j["=+.-N+<:Z08┆(NMNf0 *pHSZY  @=G)Ԁo4) ZJZ@%MmU Ml~ Dn>aʘzӤ#h4*ʬx2cJ))Ԁ('"SO 8fFz SH}9j7qe*Nê[:g"&v ]y=U2E' z]Qp?*ӑ|Ѫ+;zp0;`AsW;ym ݓ+ L7VzFN 4&iiI'R ?/JQ"~_BiyqI(QӀ3@DVdh،le})8dĒ(uU}AjN !ԔZJZ((( 4zSZCMOGlLJ5eAcQh,FEHc;[B^Ghƣt#agj{Yx xz֞p1xc yJ ,Yg=ZJl1jJ@ qJxcL(,1APrqӰv~><|zH 8iLZAJ)*[~ϥER[ !sRsJ'z= 8Yʂ,'At1*{S`ճ+ךajNn7|/yev, shLm6J3X¹;'5kznRvZ2<(#`6FI=ȲF*08A:9XH:8 AIKE(RP'jwzN܃}⡘ jkR #Џj$ FKW1ҪBB"D=ZqPJT:;t6NGI $z 1KP)j@kyǗzS_s!("N*wCß*θct津VuK`+'W!ҢDO" G) 3KKnh=)AL&OMsŊ1+0݃@ sJr@=1* >lOhGy"6*pO*| Ay6Fc լsSeX g-q@OzJ]#*F(1اvPUvԀ( AKIFjm8SQ@CIFЀ 8 9;=86jcƅB: *gU=*X;I`:xޥqRlRN)qH~9}4J0l>RPhM*{o*=Uic }ĝG*gza1TҊ3`.isM((4P!pGjM94@*ݱ ` =N`67J?JձnǭY)xp^!4N +kKtq`?tAiB2 QI0sZF:&dE'(QKJFPp#*pGPSR'^Ԁ))h4bJ( &ih"! N ( !>k (Q@ (!8- < Ns֟Q k9+¤EQFh=U|>j!Q?0QC\S7q*LRb Q@Z1\`  Ӟ)޴ Rc&ڀ`u s(Kގh9JCրiIr4L*}FxSdca *ɏd :> >u(((()aO  @Z\PFiRPXi"V̑Xcz*u*2ϭ ()H84B*{o*֧*OaʙRH0@ʙM~4JzSPiݩ(iqI)u)h Q- sKIҀ PG4Q@h#2>椢F8%-RQ@ IEQE0QIE-fL@ ER)Ѵ3۸_Ɨ4Պ4GDPc{``f@Q@E&i .#556E 2uA#*JB8pE!J` Z QJPZC(4>x ;ME%- ZLў( 4`8QH)hQ\R 4)bQHE.)@){P3H9\Mp4wP0 ?QʙO~?2)KN[ -pGF?C9\ (wlN\׶77r]}h.|=k@I&1#zu2{w3,!xjKvy>Jݜ95q}"CX%8fXٲŶ3oMci:y=:*l}9՘ ᓡnݵ${ &9jjx@`R9Z7X$ۜ1lྴderOzZkMo/RIP!<(>Ҷ<5Ǡ:T4G嫰aiZJAf(KޓcZ(4C@ `&(4P Z ZC@EQIK@Q@E-:ZB(HE0J1\ώ1c3NpzR8#޺2Ŭ=ם3 GaW7OKh"*k_)-R>7٠F6zq(e zSJFIF,,C   %# , #&')*)-0-(0%()(C   (((((((((((((((((((((((((((((((((((((((((((((((((((" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?w'$~TAEY~TgRQ@?Oʒ\ʌ?*J:'?Oʒ\?*3?*J( aQE 3򢒀?Oʌ?*)(~TgRQ@j.~~TP;A?OʊJ.}F~!8~TgRQ@.~~TP>?Oʊ( ~~TP?Oʌ?*J( F~%򤢀~T~TRP?Oʌ?*J( F~%-pϰ@ږ$(j4!Pz1(,H 4((()h JZJ -PEP0AE-Q@i:RLLZ)-QE- (((Z( J((((PGAqC!QKI@((()h)i)h(QERP!h(%Q@"y-!--%-!%-QEQEQEQ@ E-%QEQEQK@ h>PTv))Oo ( ( QIE-%P(QEQEQEQEPhQE-EP0(Q@ E-%QEQ@KHHHצhp23$w#QEQE:>#Ɗ A)hAEPEPE@'iL.$`urZ)=)X.-P;E%Z(EP (QE(J)i())nsM/4dr)>#N,b$qs^GGkqbA8ֽxhȔkľ'װm1RG.*&'  9<_ %BG?CYKIΨxWi)h"4 NO#'I#c(G89ǭ:)c)PN \5&TOZ&C¬I–<8' H00zu'[xZLnztҏ8AHB8 C$A!F֡i[LKlXO:wqBSO* CƊ#h\vAIJ(( 't HJ=j,9h%p!`zs-PVړ̙ggL>p^Dw#Rx0zc=eۘ/$g^qwGr^:^yO\\0~6$ʴ* s{~g4D۩ޢCA=pjTY2%%-RSZJ( (IڔILc}}Vr3ާqTn?J(@SXe(^~F䏥hf=#~V5 7>,[|(䞃<~5J2>dȻs3UB+^ QY9CnYJ6𾾞Բ-ْE·_o=:#$ 9f_=\l'PQ3%lye=c.`0=G\}jHP }dff Of^>j]EL:Ut=Oj+&RZ(NH!_Š%(5UܪVk_fH={f,Cy~q;zmt%Ԣh֭i62rH\'|Yeoe5IJr7rçn{VnCfș,E! iD n$=:+.>,Jׯ@ܾ7yq\cvW dٞ{tֳBi#^Ȥ>z 4ˈHRTd5WRH995j q)5O9 r˞9ɯ~'C m8'0y${—[ɼc@6]rc݄zǖU z Ձw3\F(*q{zpk?JA1W'l~cJ1idm;98U!"ʖqMWq%FH ^BːYVK1h,zaުIYY9 !M|an+6s%.;z`(cԎ:ƌs>a1Ī }?J"Y#ۀUHDZp:;yNPi0I_VX?&@ Ӛⵙ!*ISSֹi w4A+soZ\.{/X'Sb?w2{ ͵yU#h+1ǥ6Qr<'US᳻0D֊C(BQE(1XQD;n+ƾc LV%XeS" kƼm@6ld`:z.#2GQJ\^@Ҽ^n݄(r[gU=$nDy*ZWOb*/I+(Ӽ9m2I.C7XrnMgJw͸9#Ue}yvwBbb~x© s5F|͐B?mX\4]s¹m>N8\pzWKܢGbX5 :yfۂǷ-8-*M\l\AS*6-:u5jw*@dcxMpB(?.yj6@\y*$ݖ')Ͻwv" Į烜S.f f(J(R֊JZ(aEPzTnxҤ8eg'8֩K =Vjk)$=2kHM,LIPzn/I]5WJ!SI4Z-Ic;{vs] i_4Ip0Yr5FMAEb``r jÿ o5+-bk^D)zRfrM'3=}+ xMwG_ƽWbYfs^IQ/\]H`b'*7,4/=ĐE.0v A (n}NMq?K"(rO=+¾EiKi$}C95Y0cn[#$oJcMnF0?1[(ݾU6Hhr*I"oAS֭Epg"*uEfi=GQA (QE (ҹC3! + pBvO?^=kZdH 'ؓ3+dlNLJC~xy9s2Aei'6f8#<9E,Ł8 F.ιێu;7waɱ@>K6 %P8RqyrWN?NI1rN֠ 6Oqߴ_59ʀ2{tV`w9ZRSN&Q q&8;rk p@I>S;Ό>vr.XXy" $*`!=)e[h&WEey8 FWJHdaøQ8% ͊J(MB)h(PEPEPEPEP!(Z( (Q@ EP (QEE4P\vAIJzHQEQEW?I2+\F1 a'j֟R$yg"X cr+5rIq{R+e2ڤx@@zl';JF>)f њWa{(w T2Gjo823z L9_X$Olf_s6UH+>sY,#!4LA^M4mi;@;kP;{jcn$vѝDЍ_YzA0GZr€pj9cy:;dEצ鳟ƪYq,E7  !-^~f\zigbA* v`^YeKP=WrR|pH?3(5@f爩V *pG! ΚJZ(@Š(AIKERQ@Q@Q@z(#4S E%-%Q@Q@((GҊ#P\vzS)($(JE#!Azy>$#~i&G}!.ᔺq'#N>Ձوz:X5GRΰYsP\JơIm3{W}pGrw%1ɸ7p3ڵ3n涎&yd@}y> i齼ַpUa#8׎ؤ/pfC**Fqi:,ntRRfEPEPE% ZQiL.:J)QHNzQȦER((((QEQEQDx(! (?ҒB((@8UxWs\oJV«9>`L*\O22 v¡'8?A,1?v:uMHmCdgZ6%I8ϵ hfy @VU9 +^`T;z-jH&r^%G9`^~;ȶi|Z鵂\Y/qF./Ms@֮_YZp]Γ 0]P:cUrYgL`;.ΪsiO&aN9Xñ_eHsGcZRqv,Q;cj6qjt9mW~{{דA83wݼdqV𼘲P;󷃒}SJ>b4 ZJ) (((( %-QE ( ( JZ((((EEa_RPz (SHM1 \4wn9)cяLZBrEI3ynUIg]9"j*^ps$ŧ_z vj!&x,rS8O##xѣUgӧsi\hLT MIf7ch1yZDSZ@rqt7vVYc({>@19F|*w)/ٵ̄c+2ڇsrLWeDzF\gmN:nAӵv0.bFc ZRؤJ0Fyϥ8:mSx@8,5G3F`m9Y25QRPQEQEQA!1 E&)iQEQEQEQE( (IZJ(r}E !>Pz )s@ Gj(<~%FJ9c}ݻff1L\`1Z!o[ʍgT|Av_@k]Œ1$=+H %n?ZοGU*}($F?8U#_$⸽E{Hr`}3믖?fTndhج#]9<~Eq/<) )&ޟ\՞Eyb.ܕ(?*n$[n $.eM@L4)f1GZ>PH9Cņq'=JE\1f[*}˜`vPHxYUpyrs8Y5QRPQEQE(((((4J()i)h))h-Q@LK@'Z(QAHC}QEQGjg"<Ͻ4Nr2{2 r>ΦbA<1X3#R,KHQ1tK(H7 . *F@WQ3JX$#8 \uP1,cw.0y7s**Nߗo]&h6B-޹k`#@1מsRw^1,|*ta]bt7= Dm:T=u#jfRҕ X F'=qF2rMeR|68qqlMETQEQE ( ( ( ( JZJ)h ( JZ((KIL(A(bZ(~PZB?=E ER-%Dzu Եs۟_Jh9^Nx#U MWEt`<աCPB\*!#vO~-iL*E"N0rFk&|o1>RF=w m[0Qv6* 83%,T3lj!b '>Ҩf>AeEa&ߗ'#SFV $;x]eX<5hd $fܼ6^4; X"n1 UvtA0:u+<=mF#QQ2G"ij8'4(eB8MdRER((((QEQEQEQEQEJZ(J)hE(\vKIAKL(R(4Jc 短>f۞}) $ZP@=Nbܒ(~b8*+Nć8;\ l2C(8Qܴ=qRg;Sdz?^ԏJѳLmy#~<Y(PQE((((E ( 3IK@ @J(J)QE%1 @ |z#QH4QAL((SQ0ڤ8qM` M'$8i~Lql*[ŁC N.TTn8#牤UQqϭgh*9K;pGN}zbD;Hcv;5#Jӛp* 9,dahCzjAD1Nzڻ=/eln.t psN;ܖwl * sWu㊩bSt05) $^k_-a# 9)+!EV c<"J(Š((AEPEP(4 `-QH((J( Hh JZ((џDxAvR@RQKHj2Fy)#zPʄ0 t#KlңAHGy#Pww=PLJqkd!ͷ1<}s: 5ը6 <# 9Z qުhkvQWYOPߘ,- p Q%arMw 20Hl@rַt #džx?yڱT{Oiս?*$B0F̽Ҭp[50yJ9;)dWO-K`z󊑒EQE (Q@Q@Q@Q@Q@RPKH)iQFzE@-%(E}E KIE0Fh4)SE0rzS:yZk0s 8?q0D_4zZӼ>mP@ Ǿ1]O5܏9Ci8Zxi4r31#>giҙ-'LqOO튡I.9=+D=^%D܉$UB ?.r~zy22d\gH&C(ハZ󆻖M`U{VK 6=x:[{@:>+g=B(;m,pNO=8 sҘҪƐ 6HD!sYcC gwp9ɣ jMmb@*T~T*9')"IVڊO,@'ԂCERQEQEQEQE%-PEvJZ(( (h@{I((Ea?QAP@QECEvIR֖ hEAqKE(Q@ ֖!A5Ē:3Fr8GjZHInb# EEPEPEPEPE((() 0sFh))h )hSEE-?Ҋ_’E)RR@ E-QEZJ`QK@QHt}i`RZJ@Ri))iQJ(h4RRE%RQL P ( (4P)i-QE{E-AKIHaY5,A$W |(TZ]Ii$R[9 N{UìCs<ˤ!1S6\R ux@ԃQf7ɼ yM?>lu嶺F;x4Q\XxV}d p4}>VY.Tvta}(};Ǟ/(/ Fe9r8'i q]E%-H9(E)Rf@Z (AIKIL((((ERQE>Q@斀1KӭQEZ(() $,JqRIqI,BX7 S=;᷇5 zŢ`YA_6!"rO'NFƘ> ηzT7ɑ&3zo<+g[ˉ.5Wb**/[^i/u4:đ9} t(S_5}˫IEphF dqk3zՖK2h "UpvW4?g{xiO,63>`R5X4:zںh >͐+,w>s'Xʛl ԁcSR>`6}iA @#(vOWuKIR>E;ii,%>`P; nԫȠiS$p'SJ6JM%84O J]ivC@XJJvh} aSJ6C@Xmҍ#eOq׉>ޗȭnekow`|{Fӎ ǘ|S|Y Mi K"H;IQxkOZVݴFO~I_CMҗҐyFPj{}-l;$oyW 1W@ӖQү%Qhdk86'pCsҽ#ҍҀ)J;M OE'" G٠F3i T!/^dJFIF,,C   %# , #&')*)-0-(0%()(C   (((((((((((((((((((((((((((((((((((((((((((((((((((" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?xt);՜,\?*3(..~&~qs򤢁\?*3(..~>ߕ%QE%qs򤥠.~TgRQ@.~~TP?Oʌ?*J( s򤢀~TgRQ@]F~%ع~TgRQ@]F~%?Oʒ\?*3(..}F}IEqs?*3(..~~TP?Oʌʒ\}KHE1][8o*:z)*5YXS%)XU=[hQEQEQE5_np4()hQERPEPEPEP (((((((((((4Iz)%/RR%Q@((((-Q@Q@Ģ(QEQEP (QEQEQE((QE ( ( ( (z(NS-l!JJD(QE ( (Q@-%R((bQE(ZJZJ(((((QE ( P ((((Aka?ҒXQE(((((QE-%Pc0v wMR|iRRPEPEPA(QEQEQEQE"L6ࡏ9S23@Q@Q@Q@NQz(-l5%(QEQEQEQEQQ2BcUo<.Ql46ڄr[IQE!Q@bɜHC)IEQEQEQEQE(EPE(( NOSՍVGq͌qڀEPEPEPEH4%+JJaEP QEQERQ@-%{.1T~@r2H< A sI,BVDpy{L8"~ԘnTj\3u.O^k@[4Q+Š( QE64H$jSQEQEQEQEQE)3KHNr#5웎 ؞ӓ3xi);KjA"nhpnS۽jې 2J))k1 3ăv߽#4( ( (z(Ga))O(AEPEPQGzJ`-%Nr(x[kCRp,͐GwbY4=yν,|a׭i)4j)v/WxAл|y[g|a@-ۯz?NUB6\Qҳ4 ZJZ@". 8NM-6%eVG`1u ( ( ( (RSmM>p})3X1UPc.dbC \WuGumnq}m;3>vH-r,< <;IrTW_ri{p}Hm1q ┵WOpqz敮,8<[6uCЪ9*E4·>QA5(pބW.kWRxt-ZK%R<9Jl5iUCGqNJB:FjfGPUJ fC ł8>ƓgސQE((|}>Pi! )i( (ݶ5~/p<B55bA xɭ"Gjڋ$lXyl5 ֥Y7=;S"3,OJavvjhdKm ]0ڧ`;rXN@YX>*n=0"9RyX1#NG+.X1Tsҷ=x7ɐ1Uqr 1=kRlt*wR?QM = FusZ@YZ7np;֮B$I55@r`#GqKP0(QEQERZC֘׳y0+ԵxrYko pU T3\yy;2pHKP|D,~f:guG^_5O,+ +C/PJ ݃Ϋ6.7HF;֋0[zUVQ[N `ٸ{V݆Ô2{u"G z~#*pϜG4 X2QGjD9^A"v^ىv8 S""(Ḱ!)ʡsNNy9MQE (ޖ`>>Qz(-l4AM"KEP (+]\/XH!Gcl#pڠV9 FI8&#Y2yfUIkd!؀Zo\!ۀ( .obh#\Od^LSz}+%k'/Vh9^ 'Ϛf>br\}㚷xCiJH[zֹ-RWIG#v~IUp?z^\I *ټfsR8~IlP07n z׮Gg.0F38GAUGg=CN(0 +2(aEP (M4 p֎8aυdc޺a idHfBKqk;3 d>yc+}jO/tv#|Z߈KcP8k);t7+e@ Im&|!xT4@$,9*=MaY(qW#76~bTV6:[YiS!s5~lRF8o|>HEyYh,`w$Qw kgGsvyzh9lrzq0;W3) (J)$}>R4[ =IJQE JZJZ( C1; |Fڦ$'#Wjp$ ;VZȥ+AhK̲f'Jľp<ׅ'aٗ'$U.~@z=Q$l!$ 0IЌg5]|\tMRBӹS 0USz˥ϥ~ʹ)8fL 2I8%C"}ak.1Mt`u^XD1[w)S\)mҺ H$pj&ZW8QӨOAEPE@Q@1M0BaG>Eǝ!`p}_%V>(\`Et#>UvbXSt 7B@*s}}k"+kC2,ɮ?usAa@Fx?GnI#*x#9w4QEQE$}>PZiyŠ9ϵ))h)(AAH\i-ۃ9'5v}ҫhV-?1 t+2idXʏ¾}ƠBzf 6,uUg )iG:*gZ}|̠pGBz"=?՚B<,I-ʻsVޫc#GzȏOE_ 'r PaUvzנ W ~K{/]+EnLK*۞&"z@A]bo,w35+5qb^L㚙Eq9KYQEHzP)QE CMIPܰTbM9]Dۂ r82eP:d wzk߳1U=>kKy9>dyof'֙p<^2Yы8 { sTZvdG:H˒ _~ybZ5A/vC`Ag]b;Xs]Ir1ǥsZC,0q^ɦI\nU#3ވFzƅn$$`{֗ ۤO3޳:J,pT6kguVr)4r,Lg 185GFϲV j[!hC (IKI@Gފ#E:~?:QE JZJZCEWBLg/CD1k{#8ϵi[(ԎBoŎgأ>zN^^IW\R2¨"cҖ,(Ph^DLcB ECA\ƕfߢOFq= w#Qzt?<33WyOYcׯiצe,@ ^=Ud1 Bg-`"u[HÌ##ҝB/ֵ.mf o-.<%%ۣRAm]5ӢH۳G#?0]fH;]?ʮ1Wc6W=&9慹8$z7Bc;c+9`zэwit(7]P W30z]$QQaFx}nZ}b)i(EBwGS<ʤ )v܍=hb3o!grN#qTֵ(씖as!v"#+e} 8/7 3ָjZݛ+pǡc4gkH34IjC8QDpFcc⡎FFO?ƺ^ 'U8Xv{ò)ʱMfӸV6m(ͅ!Aqn)Qt' xa3y]?! $x{W鯾0G9y}* qzeUO(8--XjsjܱTd8V>x庒< -'n` \QE CHvhO(1QE!Cp29FaL j%'Zb&$=jkk5EUWO]kRq쾿ֱ98ǥX1|4sܓ:LXa:U4 IF۶VPG1GVҬi ?V qT䲎1]w1W1T's?3ݱFI}*֙1Y 0sTm,WT].%QF1+,`Hulc?c-DQE@’ ( -L*3})P($))i(=)h#>rx[KuXH ՞ ~Qא? Vw&bd\z.?Nx݂T( r6ɆJLh N9qVS/8ީi%ŵHz'Ϸp0qJs$s"7ҴRϻGNl29\W>dgPfgPWpmHw*s^+Yq߹IO?'#=:j33GS _dg]LyjoW+<͗FOjRL"If: sWEd$Q@ƿJU'CN_)E" kwSM4)Tf rk'VtH=mVnNmrYWWi!qj[O98Oַo v5lRR1zP'KokGmfȍO1m騢\0j~Y[#ĭxZPJ"DRn@Jt=E 7Y#WC`cŔ:((a)qI@^P蠤Vn$U(9 E׆$s!8<_K'a dq>Q(kQ̹ν5€kd~GlkS) iX_A>)9DF~@* @Q@?JrN^: ERSM:O5>3ZSP`lUq3ͯ!#}CyK iƟ jGEk^?.`Ҭ2z`p3GJ$#P0PH\ܜR1QEPi(:SIO)Z(!M4JJj@p:JoecYE_WO< c]Gz؃l:1Y'L EΜI}?]\W9?N @bA#|> ȿ*Ee@ZN 0r3@M_ju`)S#Q,q ; #)Ta@֐ EP0(i)i(EKlUʜ4ے ?5NmtSز-5E8 EP %!`G'*AdDw@<kZr =rkHȣ&߂A_J\dV|R8 =?ƴXΖR~n q8\NGvŀIAcQ@R UgEQE0i2Jz (AIKILBFM<@do~wjwCgt }:0/z5YtW#b=/@ͲBA֨6otI$k PX0#KC #d\! cݽ+F >iX>Uዳ2vj ZAҝX6B61σOրIp J!K:(ZCLPuoŠ!֊tC)p)uMJlGBAIKIH(!(Sp0k4{y#89OSuqm)vTⶎ=z2e[s9 ~^4;"ګpvS[{Cvydp31Ҳ8_ƀCuUY7g"&T&yz#mN;VT+D z)9)lz{}ih;qJERQA7¤*#Ԣ (AIKILAPgp:MQOL5gy39~9# r18"iFx|Ҷ3:o W^c)6f뎙]8 xYd9;AaPhĕUQv5x@9rkibxb arN;?UoAuj0//\zTEݔ<]p aklF2z}+08'9Rs±#ܑMJ6R(KU,(I8S]ԫe=A@RCZJ`QH ?[EK:it?.U~UsĢ#.)Ց JZ ( :@ĖoVOj=*P7tϽ\f!Pa*Z51+Nv*(1!hTtV8g8^:gR H=hRR ILbc)0aERSE:%-%8.۰NBZ𵿗d )=Ws;֯'vA$.h{VL@tEam%prtҴĢAKH)k"VL<)=tuQHaڊ(A@Im?}R:(~UY$Z'Z>z#L>f  B)(hPz̚Lfa"ze?% ʯU -Ҵ*gѝzehlUviLZNC0{Vd]M(J ڊkF젲TPii 4=iE1өZZB (QE0 JZ(N@'֢ӯ1I=3Uq 皰arw=W&orVזA1p['qҬ_4vסb䥲P#vq<{uhZE"yԌJn 36)W^ad 3gr1ǯZ=m܌Ѻ[ƲdPy.~ɱ ̻I5:Rm>ԛ\CF )p}(} R>m>QK6C@Xm-.hVE84O0QKQiii4RSCF@Xm-.FhN}(} aSJ6Jhm>O`iҀIN} O0U A.q#\r}*icB0U*#eFNqNݤT2?➂xu22P Ѥ6phkw2J(.3dg,qӿ<ؖ'IP4lOCNE m6X} E;i Z)-O$֊KGaR( / 00DArialngsRo8L5v 0( 0W"DTahomagsRo8L5v 0( 0W" DTimes New Roman5v 0( 00DWingdingsRoman5v 0( 0W a .  @n?" dd@  @@`` ldX(f ,,HHHH,,>>HGHG//HH,,      O8            ?R$}z#kNEER$zq(e zS6ER$i T!/^d3{ 0AA f33f3f@856[+ ʚ;ʚ;g42d2dv 0*ppp@ <4dddd` 0L6 <4BdBd 0L<4!d!d 0L___PPT10DTimes New Roman0z[ 0DArialNew Roman0z[ 0 pp?  O  =Ee_KLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 : PRIKAZ BOLESNICE Dr. Marija Despot SPEC INTERNE MEDICINE9$'$$ ' :f`KLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 f M. K. , 46 godina Ing. Graevinarstva iz Vukovara>3  3gaKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 Iz anamneze: Tonzilektomija Kolecistektomija 2X upala plua Prometni udesN >  >KhbKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 Sadaanja bolest: 1991. god. Operacija ciste na vratu u KB Osijek: PHD- CISTA 1995. Op. ciste na vratu u Klinici za tumore PHD - BRANHIOGENA CISTA 1997.god. 2 ciste na jetri  Fenestracija cista i resekcija periciste u KB Merkur ZGB- PHD-HEPATOCELULARNI CA 1997. God. UZV: recidiv u podru ju resecirane ciste desnog re~nja jetre - ekspanzivna tvorba 4,5 cm UZV trajno nepromjenjen 2001. God. Bolovi u desnoj strani prsnog koaa  RTG nalaz: Sumnja na ekspanzivni proces okrajka V rebra lijevo.ZZ1/WicKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 Sadaanja bolest: 2001. God . CT TORAKSA I ABDOMENA (hipodenzno podru je 25 mm u desnom re~nju jetre) Dvije pravilne promjene do 25 mm u desnom bubregu Zone razrijeenja kosti u jednom od distalnih Th kralje~aka i u trupu L2, promjera do 18 mm Promjena do 1 cm u plunoj bazi lijevo METASTAZE U JETRI, DESNOM BUBREGU, KRALJE`CIMA I PLUIMA ?? !! $? ?  \jdKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 2002. God. Revizija nalaza BRANHIOGENE CISTE -PHD- CA `TITNJA E (Tg pozitivan) FENESTRIRANE CISTE-META CA `TITNJA E (Tg i alfafetoprotein- pozitivni ) UZV `titnja e: nodozna struma, poveane paratireoideje i cisti na tvorba u jugulumu (Citoloaki nalaz: bez epitelnih stanica te je dg nemogua, Tg u punktatu poviaenih vrijednosti) Citoloaka punkcija tvorbe na V rebru  adenoca (jetra ?) mHEnkeKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 6 mj. 2002. God. Hospitalizirana na Klini kom odjelu KZNM U injena obrada atitnja e , UZV i citoloaka punkcija: FOLIKULARNI TUMOR sa znakovima cisti ne degeneracije Upuena na ORL radi op. zahvata. 6 mj. 2002. God. Totalna tireoidektomija s funkcionalnom disekcijom vrata lijevo . PHD: tumor veli ine 1 cm, PAPILARNI KARCINOM atitnja e, a u disektatu vrata od 9 limfnih vorova 4 pozitivna-META PAPILARNOG CA / Proboj tumora kroz ahuru, invazija okolnog tkiva kao i periglandularnog vezivnog tkiva ";ZZZ''')'3''# '' '#''''B#''# ''"'#]''x!!2lfKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 8 mj. 2002. God. Klini ki odjel KZNM- RADIOJODNA ABLACIJA s 200 mCi J-131 SCINTIGRAM CIJELOG TIJELA s 200 mCi J-131: pokazuje patoloako nakupljanje aktivnosti u projekciji desnog ramena, desnom re~nju jetre, ini se i desnom bubregu te u projekciji sredine prsnog koaa, lijevo viae sprijeda. METASTAZE U JETRI, DESNOM BUBREGU, KRALJE`CIMA I PLUIMA ?? !! pJ@''' ''#''>emgKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 $Slika scintigrama s 200 mCi J-131 ,%#%%$nhKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06  1. Mj. 2003. God. Ponovna hospitalizacija na KZNM Scintigram cijelog tijela s 5 mCi J-131: patoloako nakupljanje aktivnosti u desnom ramenu i u podru ju jetre (regresija u odnosu na raniji nalaz) Tg se nije mogao odrediti zbog prisutnosti TgAt: 372,9 l474oiKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06  CT TORAKSA I ABDOMENA: U PLUNOM PARENHIMU viae sitnih nodusa Destrukcija kosti V REBRA LIJEVO  4,2x22 cm JETRA: u oba re~nja viae sitnih ~arianih lezija, najvea lezija 2,2 cm. DESNI BUBREG: dvije tvorbe veli ine 5,6x5,3 cm i 3,1x3,1 cm LIJEVI BUBREG:LEZIJA ISTIH KARAKTERISTIKA KAO I U DESNOM BUBREGU veli ine 4,3x4,1 cm. U trupovima kraljeaaka Th 8, 9 i L2 zone razrijeenja ( mogui hemangiomi)Nz&SpjKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 h6. Mj. 2003. God.- nova RAI s 150 mCi J-131: Patoloako nakupljanje Desno rame V rebro lijevo Kaudalni dio jetre u 2 lokalizacije Vee podru je u gornjoj polovini desnog bubrega |-o-  oqkKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 #Slika scintigrama s 150 mCi J-131>$% %#rlKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 11 mj. 2003. God. Dolazi radi obrade patoloakih promjena na bubrezima PET-ne radi Scintigrafija cijelog tijela s 201- Tl Patoloako nakupljanje uz konturu lijeve klijetke te intenzivno nakupljanje u projekciji gornjeg pola lijevog bubrega UZV bubrega , IVU, abdominalna angiografija: U tumorskom procesu desnog bubrega zna ajna vaskularizacija dok je tumorski supstrat lijevog bubrega izuzetno hipovaskularan BIOPSIJA TM PROMJENE LIJEVOG BUBREGA: PHD FOLIKULARNI KARCINOM `TITNJA E (Pozitivan Tg u veini tm stanicaFZ4ZuZ-Z}ZZkZF4u-}  *#wpKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06   smKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 TERAPIJSKA DILEMA EKSTIRPACIJA TM TVORBE U LIJEVOM BUBREGU-PREZENTIRANA NA INDIKACIJSKOM SASTANKU S UROLOZIMA (ZA I PROTIV)? NOVA RAI s 200-300 mCi J 131? PAPILOFOLIKULARNI CA `TITNJA E S METASTAZAMA U PLUIMA, V REBRU LIJEVO, JETRI I BUBREZIMAfZZvnKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 8 HVALA NA PA}NJI ($$ ` r77f3/Ʊ` fff` KfxP` 7_/U<ff` HghXs3q̙` WXcklugti~^ӤO` ־3f3f` 33^` J%xiff3>?" dd@(?nFd@" d nF@ d`nF n?" dd@   @@``PP   @ ` ` p>> `(  6 T ~  "~  c B@CW DEF"d@ W @W @W W @`".~  c B,CW DEF"d@ W ,W ,@`". \ ~  "~  c B CDEF"@   @`"(4  c B C DEF"d@ @`"(W4  c BtC DEF"d@t t tt@`"~   c B CDEF"@ @`"([4W   c B CDEF"d@ @`"(4   c B CDEF"2@  @`"(4[   c BC DEF"d@ @`"_   c BC DEF"@ @`"  c BC DEF"@  @`"\  Bp ?"0F  T Click to edit Master title style! !$  00s "0  RClick to edit Master text styles Second level Third level Fourth level Fifth level!     Sx  s *S"?:  0y " F  \* `B  s *DfjJ" H  0޽h ? fff___PPT10i. @F$+D=' = @B + Shimmero 5 o(   T ~  "~~b ~ # "~  c B@CW DEF"d@ W @W @W W @`".~  c B,CW DEF"d@ W ,W ,@`".  c B CDEF"2@  @`"(4[  c BC DEF"@ @`"  c BC DEF"d@ @`"_b \~  # "\~   c B CDEF"@   @`"(4   c B C DEF"d@ @`"(W4   c BtC DEF"d@t t tt@`"~   c B CDEF"@ @`"([4W  c B CDEF"d@ @`"(4  c BC DEF"@  @`"\  Hx ?"p  T Click to edit Master title style! !  0( " `   W#Click to edit Master subtitle style$ $  0m "`P  \*   0$ "`@`   ^*   0) "`0  ^* x  s *S"?:`B  s *DfjJ" H  0޽h ? fff80___PPT10. @F$50 zr (    0 ] P   ] P*    0l]    ] R*  d  c $ ?  ]  0$]  0 ] RClick to edit Master text styles Second level Third level Fourth level Fifth level!     S  64] _P  ] P*    6$] _  ] R*  H  0޽h ? 3380___PPT10. \ 5 0$(  r  S ՜p   r  S ؜0  H  0޽h ? fff 5 @$(  r  S (@0F   r  S @0  H  0޽h ? fff 5 P$(  r  S 0F   r  S h0  H  0޽h ? fff 5 `$(  r  S ,0F   r  S +@0   H  0޽h ? fff 5 p$(  r  S d0F   r  S 0  H  0޽h ? fff 5 $(  r  S l0F   r  S 0  H  0޽h ? fff 5 $(  r  S Xĩ0F   r  S ũ0  H  0޽h ? fff 5 $(  r  S 0F   r  S 30  H  0޽h ? fffp 5  (  r  S ٩0F   r  S ک0    C \ADC:\WINDOWS\Desktop\Untitled-1.jpg =H  0޽h ? fff 5 $(  r  S 0F   r  S `0  H  0޽h ? fff 5 $(  r  S @0F   r  S u0  H  0޽h ? fff 5 $(  r  S ']0F  ] r  S (]0 ] H  0޽h ? fffp 5  (  r  S .]0F  ] r  S ]0 ]   C \ADC:\WINDOWS\Desktop\Untitled-6.jpg0 }H  0޽h ? fff 5   $(   r   S Ɯ0F   r   S xǜ0  H   0޽h ? fffp 5   $(  $r $ S ,4]0F  ] r $ S 4]0 ]  $ C \ADC:\WINDOWS\Desktop\Untitled-4.jpg. H $ 0޽h ? fff 5 0$(  r  S :]0F  ] r  S <;]0 ] H  0޽h ? fff 5 @$(  r  S ,@]0F  ] r  S @]0 ] H  0޽h ? fffrd0iRh {emYE1 YE1v h ѣwpaR( / 00DArialngsRo 9,46|dv 0|( 0W"DTahomagsRo 9,46|dv 0|( 0W" DTimes New Roman46|dv 0|( 00DWingdingsRoman46|dv 0|( 0W aOh+'0Q hp  Slide 1MakinenShimmer10000w480Microsoft PowerPointP@!9j@\@*|GPg  R('& &&#TNPPH2OMi & TNPP &&TNPP     'A x(xKʦ """)))UUUMMMBBB999|PP3f3333f333ff3fffff3f3f̙f3333f3333333333f3333333f3f33ff3f3f3f3333f3333333f3̙33333f333ff3ffffff3f33f3ff3f3f3ffff3fffffffff3fffffff3f̙ffff3ff333f3ff33fff33f3ff̙3f3f3333f333ff3fffff̙̙3̙f̙̙̙3f̙3f3f3333f333ff3fffff3f3f̙3ffffffffff!___www _________________________________________________________________________ ____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ _ _ _ _ _ _ _ _ _ _ __ _ _ __ _ _ _ ___ _ __ __ _ _ ___ _ _ _ ___ _ ___ _ ____ _ _ _ _ __ _ _ ________________________________________ _ _ ______ ____ _ _ _ ____ _ _ _ _ _ _ __ _ _ __ ____ __ _ _ _ _ _ ___ ____ __ _ _ ___________________________________________ __ _ _ ___ __ _ __ _ _ __ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ ___ _ __ _ _ _ _ _ ________________________________________________________________________________________________________________________ ___________________________ _____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________--&TNPP &es New Roman46|dv 0|( 00DWingdingsRoman46|dv 0|( 0W a .  @n?" dd@  @@`` ldX(f ,,HHHH,,>>HGHG//HH,,      O8            ?R$}z#kNEER$zq(e zS6ER$i T!/^d3{ 0AA f33f3f@856[+ ʚ;ʚ;g42d2dv 0pppp@ <4dddd` 0, 7 <4BdBd 0,6<4!d!d 0,___PPT10DTimes New Roman0z[ 0DArialNew Roman0z[ 0 pp?  O  =Ee_KLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 : PRIKAZ BOLESNICE Dr. Marija Despot SPEC INTERNE MEDICINE9$'$$ ' :f`KLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 f M. K. , 46 godina Ing. Graevinarstva iz Vukovara>3  3gaKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 Iz anamneze: Tonzilektomija Kolecistektomija 2X upala plua Prometni udesN >  >KhbKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 Sadaanja bolest: 1991. god. Operacija ciste na vratu u KB Osijek: PHD- CISTA 1995. Op. ciste na vratu u Klinici za tumore PHD - BRANHIOGENA CISTA 1997.god. 2 ciste na jetri  Fenestracija cista i resekcija periciste u KB Merkur ZGB- PHD-HEPATOCELULARNI CA 1997. God. UZV: recidiv u podru ju resecirane ciste desnog re~nja jetre - ekspanzivna tvorba 4,5 cm UZV trajno nepromjenjen 2001. God. Bolovi u desnoj strani prsnog koaa  RTG nalaz: Sumnja na ekspanzivni proces okrajka V rebra lijevo.ZZ1/WicKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 Sadaanja bolest: 2001. God . CT TORAKSA I ABDOMENA (hipodenzno podru je 25 mm u desnom re~nju jetre) Dvije pravilne promjene do 25 mm u desnom bubregu Zone razrijeenja kosti u jednom od distalnih Th kralje~aka i u trupu L2, promjera do 18 mm Promjena do 1 cm u plunoj bazi lijevo METASTAZE U JETRI, DESNOM BUBREGU, KRALJE`CIMA I PLUIMA ?? !! $? ?  \jdKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 2002. God. Revizija nalaza BRANHIOGENE CISTE -PHD- CA `TITNJA E (Tg poziti  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root EntrydO)96|@PicturesCurrent User2SummaryInformation(QPowerPoint Document(XIDocumentSummaryInformation8 .  @n?" dd@  @@`` ldX(f ,,HHHH,,>>HGHG//HH,,      O8            ?R$}z#kNEER$zq(e zS6ER$i T!/^d3{ 0AA f33f3f@856[+ ʚ;ʚ;g42d2dv 0pppp@ <4dddd` 0, 7 <4BdBd 0,6<4!d!d 0,___PPT10DTimes New Roman0z[ 0DArialNew Roman0z[ 0 pp?  O  =Ee_KLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 : PRIKAZ BOLESNICE Dr. Marija Despot SPEC INTERNE MEDICINE9$'$$ ' :f`KLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 f M. K. , 46 godina Ing. Graevinarstva iz Vukovara>3  3gaKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 Iz anamneze: Tonzilektomija Kolecistektomija 2X upala plua Prometni udesN >  >KhbKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 Sadaanja bolest: 1991. god. Operacija ciste na vratu u KB Osijek: PHD- CISTA 1995. Op. ciste na vratu u Klinici za tumore PHD - BRANHIOGENA CISTA 1997.god. 2 ciste na jetri  Fenestracija cista i resekcija periciste u KB Merkur ZGB- PHD-HEPATOCELULARNI CA 1997. God. UZV: recidiv u podru ju resecirane ciste desnog re~nja jetre - ekspanzivna tvorba 4,5 cm UZV trajno nepromjenjen 2001. God. Bolovi u desnoj strani prsnog koaa  RTG nalaz: Sumnja na ekspanzivni proces okrajka V rebra lijevo.ZZ1/WicKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 Sadaanja bolest: 2001. God . CT TORAKSA I ABDOMENA (hipodenzno podru je 25 mm u desnom re~nju jetre) Dvije pravilne promjene do 25 mm u desnom bubregu Zone razrijeenja kosti u jednom od distalnih Th kralje~aka i u trupu L2, promjera do 18 mm Promjena do 1 cm u plunoj bazi lijevo METASTAZE U JETRI, DESNOM BUBREGU, KRALJE`CIMA I PLUIMA ?? !! $? ?  \jdKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 2002. God. Revizija nalaza BRANHIOGENE CISTE -PHD- CA `TITNJA E (Tg pozitivan) FENESTRIRANE CISTE-META CA `TITNJA E (Tg i alfafetoprotein- pozitivni ) UZV `titnja e: nodozna struma, poveane paratireoideje i cisti na tvorba u jugulumu (Citoloaki nalaz: bez epitelnih stanica te je dg nemogua, Tg u punktatu poviaenih vrijednosti) Citoloaka punkcija tvorbe na V rebru  adenoca (jetra ?) mHEnkeKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 6 mj. 2002. God. Hospitalizirana na Klini kom odjelu KZNM U injena obrada atitnja e , UZV i citoloaka punkcija: FOLIKULARNI TUMOR sa znakovima cisti ne degeneracije Upuena na ORL radi op. zahvata. 6 mj. 2002. God. Totalna tireoidektomija s funkcionalnom disekcijom vrata lijevo . PHD: tumor veli ine 1 cm, PAPILARNI KARCINOM atitnja e, a u disektatu vrata od 9 limfnih vorova 4 pozitivna-META PAPILARNOG CA / Proboj tumora kroz ahuru, invazija okolnog tkiva kao i periglandularnog vezivnog tkiva ";ZZZ''')'3''# '' '#''''B#''# ''"'#]''x!!2lfKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 8 mj. 2002. God. Klini ki odjel KZNM- RADIOJODNA ABLACIJA s 200 mCi J-131 SCINTIGRAM CIJELOG TIJELA s 200 mCi J-131: pokazuje patoloako nakupljanje aktivnosti u projekciji desnog ramena, desnom re~nju jetre, ini se i desnom bubregu te u projekciji sredine prsnog koaa, lijevo viae sprijeda. METASTA      !"#$%&'()*+,-./ZE U JETRI, DESNOM BUBREGU, KRALJE`CIMA I PLUIMA ?? !! pJ@''' ''#''>emgKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 $Slika scintigrama s 200 mCi J-131 ,%#%%$nhKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06  1. Mj. 2003. God. Ponovna hospitalizacija na KZNM Scintigram cijelog tijela s 5 mCi J-131: patoloako nakupljanje aktivnosti u desnom ramenu i u podru ju jetre (regresija u odnosu na raniji nalaz) Tg se nije mogao odrediti zbog prisutnosti TgAt: 372,9 l474oiKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06  CT TORAKSA I ABDOMENA: U PLUNOM PARENHIMU viae sitnih nodusa Destrukcija kosti V REBRA LIJEVO  4,2x22 cm JETRA: u oba re~nja viae sitnih ~arianih lezija, najvea lezija 2,2 cm. DESNI BUBREG: dvije tvorbe veli ine 5,6x5,3 cm i 3,1x3,1 cm LIJEVI BUBREG:LEZIJA ISTIH KARAKTERISTIKA KAO I U DESNOM BUBREGU veli ine 4,3x4,1 cm. U trupovima kraljeaaka Th 8, 9 i L2 zone razrijeenja ( mogui hemangiomi)Nz&SpjKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 h6. Mj. 2003. God.- nova RAI s 150 mCi J-131: Patoloako nakupljanje Desno rame V rebro lijevo Kaudalni dio jetre u 2 lokalizacije Vee podru je u gornjoj polovini desnog bubrega |-o-  oqkKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 #Slika scintigrama s 150 mCi J-131>$% %#rlKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 11 mj. 2003. God. Dolazi radi obrade patoloakih promjena na bubrezima PET-ne radi Scintigrafija cijelog tijela s 201- Tl Patoloako nakupljanje uz konturu lijeve klijetke te intenzivno nakupljanje u projekciji gornjeg pola lijevog bubrega UZV bubrega , IVU, abdominalna angiografija: U tumorskom procesu desnog bubrega zna ajna vaskularizacija dok je tumorski supstrat lijevog bubrega izuzetno hipovaskularan BIOPSIJA TM PROMJENE LIJEVOG BUBREGA: PHD FOLIKULARNI KARCINOM `TITNJA E (Pozitivan Tg u veini tm stanicaFZ4ZuZ-Z}ZZkZF4u-}  *#wpKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06   smKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 TERAPIJSKA DILEMA EKSTIRPACIJA TM TVORBE U LIJEVOM BUBREGU-PREZENTIRANA NA INDIKACIJSKOM SASTANKU S UROLOZIMA (ZA I PROTIV)? NOVA RAI s 200-300 mCi J 131? PAPILOFOLIKULARNI CA `TITNJA E S METASTAZAMA U PLUIMA, V REBRU LIJEVO, JETRI I BUBREZIMAfZZvnKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 8 HVALA NA PA}NJI ($$ra =wFaR( / 00DArialngsRo 9,46|dv 0|( 0W"DTahomagsRo 9,46|dv 0|( 0W" DTim ՜.+,0    gOn-screen ShowMeGareeIh ArialTahomaTimes New Roman WingdingsShimmerHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAEHKLINIKA ZA NUKLEARNU MEDICINU I ZATITU OD ZRAENJA KARCINOM TITNJAE  Fonts UsedDesign Template Slide Titles_wI10000w10000wvan) FENESTRIRANE CISTE-META CA `TITNJA E (Tg i alfafetoprotein- pozitivni ) UZV `titnja e: nodozna struma, poveane paratireoideje i cisti na tvorba u jugulumu (Citoloaki nalaz: bez epitelnih stanica te je dg nemogua, Tg u punktatu poviaenih vrijednosti) Citoloaka punkcija tvorbe na V rebru  adenoca (jetra ?) mHEnkeKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 6 mj. 2002. God. Hospitalizirana na Klini kom odjelu KZNM U injena obrada atitnja e , UZV i citoloaka punkcija: FOLIKULARNI TUMOR sa znakovima cisti ne degeneracije Upuena na ORL radi op. zahvata. 6 mj. 2002. God. Totalna tireoidektomija s funkcionalnom disekcijom vrata lijevo . PHD: tumor veli ine 1 cm, PAPILARNI KARCINOM atitnja e, a u disektatu vrata od 9 limfnih vorova 4 pozitivna-META PAPILARNOG CA / Proboj tumora kroz ahuru, invazija okolnog tkiva kao i periglandularnog vezivnog tkiva ";ZZZ''')'3''# '' '#''''B#''# ''"'#]''x!!2lfKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 8 mj. 2002. God. Klini ki odjel KZNM- RADIOJODNA ABLACIJA s 200 mCi J-131 SCINTIGRAM CIJELOG TIJELA s 200 mCi J-131: pokazuje patoloako nakupljanje aktivnosti u projekciji desnog ramena, desnom re~nju jetre, ini se i desnom bubregu te u projekciji sredine prsnog koaa, lijevo viae sprijeda. METASTAZE U JETRI, DESNOM BUBREGU, KRALJE`CIMA I PLUIMA ?? !! pJ@''' ''#''>emgKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 $Slika scintigrama s 200 mCi J-131 ,%#%%$nhKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06  1. Mj. 2003. God. Ponovna hospitalizacija na KZNM Scintigram cijelog tijela s 5 mCi J-131: patoloako nakupljanje aktivnosti u desnom ramenu i u podru ju jetre (regresija u odnosu na raniji nalaz) Tg se nije mogao odrediti zbog prisutnosti TgAt: 372,9 l474oiKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06  CT TORAKSA I ABDOMENA: U PLUNOM PARENHIMU viae sitnih nodusa Destrukcija kosti V REBRA LIJEVO  4,2x22 cm JETRA: u oba re~nja viae sitnih ~arianih lezija, najvea lezija 2,2 cm. DESNI BUBREG: dvije tvorbe veli ine 5,6x5,3 cm i 3,1x3,1 cm LIJEVI BUBREG:LEZIJA ISTIH KARAKTERISTIKA KAO I U DESNOM BUBREGU veli ine 4,3x4,1 cm. U trupovima kraljeaaka Th 8, 9 i L2 zone razrijeenja ( mogui hemangiomi)Nz&SpjKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 h6. Mj. 2003. God.- nova RAI s 150 mCi J-131: Patoloako nakupljanje Desno rame V rebro lijevo Kaudalni dio jetre u 2 lokalizacije Vee podru je u gornjoj polovini desnog bubrega |-o-  oqkKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 #Slika scintigrama s 150 mCi J-131>$% %#rlKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 11 mj. 2003. God. Dolazi radi obrade patoloakih promjena na bubrezima PET-ne radi Scintigrafija cijelog tijela s 201- Tl Patoloako nakupljanje uz konturu lijeve klijetke te intenzivno nakupljanje u projekciji gornjeg pola lijevog bubrega UZV bubrega , IVU, abdominalna angiografija: U tumorskom procesu desnog bubrega zna ajna vaskularizacija dok je tumorski supstrat lijevog bubrega izuzetno hipovaskularan BIOPSIJA TM PROMJENE LIJEVOG BUBREGA: PHD FOLIKULARNI KARCINOM `TITNJA E (Pozitivan Tg u veini tm stanicaFZ4ZuZ-Z}ZZkZF4u-}  *#wpKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06   smKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 TERAPIJSKA DILEMA EKSTIRPACIJA TM TVORBE U LIJEVOM BUBREGU-PREZENTIRANA NA INDIKACIJSKOM SASTANKU S UROLOZIMA (ZA I PROTIV)? NOVA RAI s 200-300 mCi J 131? PAPILOFOLIKULARNI CA `TITNJA E S METASTAZAMA U PLUIMA, V REBRU LIJEVO, JETRI I BUBREZIMAfZZvnKLINIKA ZA NUKLEARNU MEDICINU I ZA`TITU OD ZRA ENJA KARCINOM `TITNJA EhH4 '  06 8 HVALA NA PA}NJI ($$r gIwF